Breaking: Terminal Cancer Patients in Remission After New T-Cell Therapy

  • by: Lead Stories Staff

Scientists are touting a new clinical trial for terminally ill blood cancer patients an "extraordinary" success after half the participants in one study went into complete remission.

The trial involves using specially engineered T-cells - a type of white blood cell which plays a key role in detecting abnormal cells - to target cancers.

One study has seen 94 percent of participants with acute lymphoblastic leukaemia (ALL) cleared of all symptoms.

Patients with other forms of blood cancer had response rates upwards of 80 percent, while more than 50 percent experienced total remission.

"This is unprecedented in medicine, to be honest, to get response rates in this range in these very advanced patients," researcher Stanley Riddell said.

The trial involves genetically modifying patient's T-cells to give them "receptor" molecules that target and kill cancer cells.

cancer scan.jpg

Riddell and his colleagues constantly refine the process. They recently revised their CAR T-cell treatment protocols to increase effectiveness and reduce negative side effects, which can include neurological symptoms and "cytokine release syndrome," with fevers and drops in blood pressure. Meanwhile, scientists in his lab are working to modify the technology to apply it to a wider range of cancers, and they are developing the next generation of engineered T cells, which are expected to be safer and easier to design.

Click here to read the full story.

Lead Stories' Trendolizer™ is constantly scouring the web for the hottest news, viral videos and images.

Follow us on Facebook and Twitter @LeadStoriesCom for your daily news.

About Us

International Fact-Checking Organization Meta Third-Party Fact Checker

Lead Stories is a fact checking website that is always looking for the latest false, misleading, deceptive or inaccurate stories, videos or images going viral on the internet.
Spotted something? Let us know!.

Lead Stories is a:


Subscribe to our newsletter

* indicates required

Please select all the ways you would like to hear from Lead Stories LLC:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Most Read

Most Recent

Share your opinion